Drugs / perfosfamide
perfosfamide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00002634 | Feb 1995 → Sep 2004 | neuroblastoma | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00002552 Background | Oct 1993 → Sep 2001 | plasma cell neoplasm | Barbara Ann Karmanos Cancer Institute | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | perfosfamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002634 ↗ |
| Known as | 4-hydroperoxycyclophosphamide | ChEMBL registry synonym — accepted as the source's own label CHEMBL61511 ↗ |
| Known as | NSC-181815 | ChEMBL registry synonym — accepted as the source's own label CHEMBL61511 ↗ |
| Known as | Perfosfamida | ChEMBL registry synonym — accepted as the source's own label CHEMBL61511 ↗ |
| Known as | Pergamid | ChEMBL registry synonym — accepted as the source's own label CHEMBL61511 ↗ |
| Modality | Small molecule | — CHEMBL61511 ↗ |